US$ 20.61
dihexa clinical trials human in Trials: What We've Learned So Far dihexa human studies clinical trials
Description
For use as a supplemental nutritive source of vitamin B12 in dogs, cats, and horses

The vaccine is being evaluated in two age-specific cohorts: cohort A with healthy adults over 65 years, and cohort B with healthy adults between 50 and 65 years

This approach helps identify any sensitivity while still providing therapeutic levels
The cardiovascular signal
